Surveillance at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam | CDC RFA IP17 1702

Opportunity Information: Apply for CDC RFA IP17 1702

The grant opportunity titled "Surveillance at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam" (Funding Opportunity Number CDC RFA IP17-1702) is a U.S. government public health funding announcement focused on strengthening surveillance for influenza and other zoonotic diseases where animal and human health risks overlap in Vietnam. It is offered by the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), specifically through NCIRD (the National Center for Immunization and Respiratory Diseases). The overall purpose is to improve the ability to detect, monitor, and respond to infections that can jump between animals and humans, with an emphasis on influenza as well as other zoonoses of concern.

This funding is offered as a discretionary award using a Cooperative Agreement funding instrument. That matters because a cooperative agreement typically involves substantial involvement by CDC in the project compared to a standard grant. In practice, that often means the recipient would implement country-based surveillance and response activities while coordinating closely with CDC on technical approaches, surveillance design, data sharing, laboratory methods, and performance monitoring. The funding activity category is listed as Health, and it is associated with CFDA number 93.283, which is commonly linked with CDC influenza-related public health programs.

The opportunity was created on April 26, 2017, with an original application closing date of June 16, 2017. Applications were required to be submitted electronically by 5:00 p.m. Eastern Time on the due date, which is a standard federal deadline requirement and typically strict. The announcement indicates an award ceiling of $1,000,000, and the expected number of awards is one, suggesting this was designed as a single, sizable cooperative agreement to support a focused set of surveillance activities rather than multiple smaller projects spread across different recipients.

Eligibility is listed broadly as "Others," with a note to consult the full announcement text under "Additional Information on Eligibility" for the exact eligible applicant types. In CDC funding announcements, this kind of language often means eligibility may include a specific set of institutions such as non-profits, universities, research organizations, or other entities with demonstrated capacity to run international public health programs, and sometimes may also include certain governmental or quasi-governmental partners depending on the announcement terms. Because the provided source data does not include the detailed eligibility language, the safe interpretation is that applicants needed to confirm eligibility in the full RFA before applying.

In plain terms, the project supported by this opportunity would be expected to build or enhance surveillance at the points where zoonotic transmission is most likely, such as live animal markets, farms, slaughter or processing environments, and healthcare settings where people exposed to animals may seek care. For influenza and similar zoonotic threats, this kind of animal-human interface surveillance usually involves coordinated sampling and reporting across human and animal health sectors, laboratory testing and characterization of detected viruses or pathogens, timely analysis and sharing of findings, and defined procedures for escalating investigations when unusual events appear (for example, a novel influenza strain detected in animals, or a cluster of severe respiratory illness in humans with animal exposure). While the specific work plan details are not included in the excerpt you shared, the title and CDC program area strongly indicate a One Health approach, meaning integrated work across human health, animal health, and environmental or agricultural partners to spot emerging threats early and reduce the risk of wider spread.

Overall, this announcement represents a targeted CDC investment in Vietnam to improve early warning and situational awareness for influenza and other zoonotic diseases at the animal-human interface, using a cooperative agreement model, with up to $1,000,000 available for one award and a mid-2017 application window.

• The Department of Health and Human Services, Centers for Disease Control - NCIRD in the health sector is offering a public funding opportunity titled "Surveillance at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283.
• This funding opportunity was created on Apr 26, 2017.
• Applicants must submit their applications by Jun 16, 2017 Electronically submitted applications must be submitted no later than 500 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA IP17 1702

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: